Ventilator- associated pneumonia (VAP) is a common and serious problem that develops after more than 48 h of mechanical ventilation. Improving the activity of immune system with vitamin D, and its consequent impact on prognostic biomarkers of VAP was studied in the current study. A randomized double blind placebo controlled clinical trial was designed. A total of 46 patients with VAP, who were suffering from vitamin D deficiency, were randomly allocated into the study groups of placebo (n = 22) and treatment (n = 24) The treatment group received 300,000 units of intramuscular vitamin D. Serum levels of procalcitonin and vitamin D along with SOFA and CPIS scores were determined at baseline and on day 7 after intervention. The mortality rate of patients was also monitored for the succeeding 28 days after the injection. The administration of vitamin D significantly enhanced its levels (P<0.0001) in the treated patients (12.28 +/- 8.26) in comparison to placebo group (1.15 +/- 1.50). The levels of PCT were significantly decreased (p = 0.001) in the treatment group (-0.02 +/- 0.59 ng/mL) compared to that of placebo group (0.68 +/- 1.03 ng/mL). However, changes in (SOFA) and CPIS scores were not significantly different between study groups (p = 0.63 and p = 0.32, respectively). Interestingly, the mortality rate of patients in the treatment group (5/24) was significantly lower (p = 0.04) than that of the placebo group (11/22). In conclusion, our results indicate that vitamin D supplementation can significantly reduce the procalcitonin in (VAP) patients, and must be considered as a preventive and/or therapeutic strategy.
16 February 2022 in European Journal of Clinical Pharmacology
Datura spp. is a potentially poisonous plant that is widely spread and is simply accessible, which can yield poisoning with a central and peripheral anticholinergic effect. We reported cases of family poisoning caused by the herbal tea with refreshing effects that were identified as Datura spp.